Table 1.
Demographic and clinical data of healthy subjects (HS) and multiple sclerosis (MS) and neuromyelitis optica (NMO) patients.
| HS (n = 25) | MS (n = 25) | NMO (n = 30) | ||
|---|---|---|---|---|
| Gender | F/M | 18/7 | 18/7 | 25/5 |
| Age (year) | Range | 16–54 | 16–53 | 13–55 |
| Mean±SE | 34.84 ± 2.24 | 33.48 ± 2.15 | 35.43 ± 2.28 | |
| Age at onset (year) | Range | – | 6–51 | 11–53 |
| Mean±SE | – | 29.60 ± 2.18 | 29.37 ± 2.14 | |
| Disease duration (year) | Range | – | 0.25–11.92 | 0.17–21.50 |
| Mean±SE | – | 3.91 ± 0.53 | 5.58 ± 0.87 | |
| ARR | Range | – | 0.29–8.00 | 0.09–12.00 |
| Mean±SE | – | 1.48 ± 0.32 | 1.69 ± 0.41 | |
| EDSS | Range | – | 0–5.0 | 1–6.5 |
| Mean±SE | – | 1.92 ± 1.39 | 3.07 ± 0.31** | |
HS, healthy subjects, MS, multiple sclerosis, NMO, neuromyelitis optica, EDSS, expanded disability status scales; ARR, annual relapse rate.
P < 0.01.